(D46.3) Рефрактерная анемия с избытком бластов с трансформацией

More details coming soon

Icon
2 030 090 in individuals diagnosis рефрактерная анемия с избытком бластов с трансформацией confirmed
Icon
215 512 deaths with diagnosis рефрактерная анемия с избытком бластов с трансформацией
Icon
11% mortality rate associated with the disease рефрактерная анемия с избытком бластов с трансформацией

Diagnosis рефрактерная анемия с избытком бластов с трансформацией is diagnosed Men are 4.72% more likely than Women

1 062 928

Men receive the diagnosis рефрактерная анемия с избытком бластов с трансформацией

122 283 (11.5 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
967 162

Women receive the diagnosis рефрактерная анемия с избытком бластов с трансформацией

93 229 (9.6 %)

Died from this diagnosis.

Risk Group for the Disease рефрактерная анемия с избытком бластов с трансформацией - Men and Women aged 75-79

Icon
In Men diagnosis is most often set at age 0-95+
Icon
in in men, the disease manifests at any agein in women, the disease manifests at any age
Icon
In Women diagnosis is most often set at age 0-95+

Disease Features рефрактерная анемия с избытком бластов с трансформацией

Icon
Absence or low individual and public risk
Icon

Рефрактерная анемия с избытком бластов с трансформацией - what does this mean

Refractory anemia with excess blasts with transformation is a myelodysplastic syndrome characterized by anemia, excess blasts in the bone marrow, and transformation to acute myeloid leukemia. it is caused by a combination of genetic and environmental factors, resulting in the production of abnormal blood cells.

What happens during the disease - рефрактерная анемия с избытком бластов с трансформацией

Refractory anemia with excess blasts with transformation is a form of myelodysplastic syndrome (mds) characterized by a decrease in red blood cells and an increase in blasts, which are immature white blood cells. the underlying cause of this condition is a genetic mutation in the bone marrow, which leads to an inability to produce healthy blood cells. this mutation disrupts the process of hematopoiesis, resulting in an accumulation of blasts in the bone marrow and a decreased production of mature red blood cells.

Clinical Pattern

More details coming soon

How does a doctor diagnose

More details coming soon

Treatment and Medical Assistance

More details coming soon
Icon
12 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Рефрактерная анемия с избытком бластов с трансформацией - Prevention

More details coming soon